Cargando…

Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer

A high percentage of marketed drugs suffer from poor water solubility and require an appropriate technique to increase their solubility. This study aims to compare physically modified and unmodified gum polymers extracted from Ziziphus spina-christi fruits as solid dispersion carriers for some drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwossabi, Ameen M., Elamin, Eltayeb S., Ahmed, Elhadi M.M., Abdelrahman, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257872/
https://www.ncbi.nlm.nih.gov/pubmed/35812143
http://dx.doi.org/10.1016/j.jsps.2022.04.002
_version_ 1784741420133777408
author Alwossabi, Ameen M.
Elamin, Eltayeb S.
Ahmed, Elhadi M.M.
Abdelrahman, Mohammed
author_facet Alwossabi, Ameen M.
Elamin, Eltayeb S.
Ahmed, Elhadi M.M.
Abdelrahman, Mohammed
author_sort Alwossabi, Ameen M.
collection PubMed
description A high percentage of marketed drugs suffer from poor water solubility and require an appropriate technique to increase their solubility. This study aims to compare physically modified and unmodified gum polymers extracted from Ziziphus spina-christi fruits as solid dispersion carriers for some drugs. Taguchi Orthogonal Design (L9) was chosen for the screening and optimization of the solid dispersions. The design has four factors: type of drug, type of polymer, type of solid dispersion process, and drug to polymer ratio. Each factor was varied in three stages and the total number of runs was 9 in triplicate. The polymer was physically modified by heating (M1ZG) or freeze-drying (M2ZG). The drugs were selected according to the biopharmaceutical classification system, namely loratadine and glimepiride (class II) and furosemide (class IV). Drugs were dispersed in the polymer in three different ratios 1: 1, 1: 2, and 1: 3. Solid dispersions were made by co-grinding, solvent evaporation, and kneading methods. Modified and unmodified polymers were characterized in terms of their organoleptic properties, solubility, powder flowability, density, viscosity, swelling index, and water retention capacity. Solid dispersions were characterized in terms of percentage practical yield, solubility improvement, and drug compatibility. The results showed that the organoleptic properties of polymers were not changed by the gum modification. The swelling index of the polymer was doubled in M1ZG. The viscosity and water retention capacity of the polymer was increased in both modified polymers. All solid dispersions showed a high practical percentage yield of more than 93%, the higher values ​​being more associated with loratadine and furosemide than with glimepiride. The improvement in solubility was observed in all solid dispersions prepared, the values ​​varying with the pH of the medium and the method of modification. The FTIR results indicated that there was no chemical interaction between these drugs and the polymer used. Analysis of the results according to the Taguchi orthogonal design indicated 51 folds aqueous solubility enhancement for loratadine using M2ZG polymer at a ratio of 1: 3 of Drug: polymer. This study showed the possibility of improving the solubility of other poorly soluble drugs.
format Online
Article
Text
id pubmed-9257872
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92578722022-07-07 Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer Alwossabi, Ameen M. Elamin, Eltayeb S. Ahmed, Elhadi M.M. Abdelrahman, Mohammed Saudi Pharm J Original Article A high percentage of marketed drugs suffer from poor water solubility and require an appropriate technique to increase their solubility. This study aims to compare physically modified and unmodified gum polymers extracted from Ziziphus spina-christi fruits as solid dispersion carriers for some drugs. Taguchi Orthogonal Design (L9) was chosen for the screening and optimization of the solid dispersions. The design has four factors: type of drug, type of polymer, type of solid dispersion process, and drug to polymer ratio. Each factor was varied in three stages and the total number of runs was 9 in triplicate. The polymer was physically modified by heating (M1ZG) or freeze-drying (M2ZG). The drugs were selected according to the biopharmaceutical classification system, namely loratadine and glimepiride (class II) and furosemide (class IV). Drugs were dispersed in the polymer in three different ratios 1: 1, 1: 2, and 1: 3. Solid dispersions were made by co-grinding, solvent evaporation, and kneading methods. Modified and unmodified polymers were characterized in terms of their organoleptic properties, solubility, powder flowability, density, viscosity, swelling index, and water retention capacity. Solid dispersions were characterized in terms of percentage practical yield, solubility improvement, and drug compatibility. The results showed that the organoleptic properties of polymers were not changed by the gum modification. The swelling index of the polymer was doubled in M1ZG. The viscosity and water retention capacity of the polymer was increased in both modified polymers. All solid dispersions showed a high practical percentage yield of more than 93%, the higher values ​​being more associated with loratadine and furosemide than with glimepiride. The improvement in solubility was observed in all solid dispersions prepared, the values ​​varying with the pH of the medium and the method of modification. The FTIR results indicated that there was no chemical interaction between these drugs and the polymer used. Analysis of the results according to the Taguchi orthogonal design indicated 51 folds aqueous solubility enhancement for loratadine using M2ZG polymer at a ratio of 1: 3 of Drug: polymer. This study showed the possibility of improving the solubility of other poorly soluble drugs. Elsevier 2022-06 2022-04-07 /pmc/articles/PMC9257872/ /pubmed/35812143 http://dx.doi.org/10.1016/j.jsps.2022.04.002 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Alwossabi, Ameen M.
Elamin, Eltayeb S.
Ahmed, Elhadi M.M.
Abdelrahman, Mohammed
Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer
title Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer
title_full Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer
title_fullStr Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer
title_full_unstemmed Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer
title_short Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer
title_sort solubility enhancement of some poorly soluble drugs by solid dispersion using ziziphus spina-christi gum polymer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257872/
https://www.ncbi.nlm.nih.gov/pubmed/35812143
http://dx.doi.org/10.1016/j.jsps.2022.04.002
work_keys_str_mv AT alwossabiameenm solubilityenhancementofsomepoorlysolubledrugsbysoliddispersionusingziziphusspinachristigumpolymer
AT elamineltayebs solubilityenhancementofsomepoorlysolubledrugsbysoliddispersionusingziziphusspinachristigumpolymer
AT ahmedelhadimm solubilityenhancementofsomepoorlysolubledrugsbysoliddispersionusingziziphusspinachristigumpolymer
AT abdelrahmanmohammed solubilityenhancementofsomepoorlysolubledrugsbysoliddispersionusingziziphusspinachristigumpolymer